A randomised, placebo-controlled, double-blind study to evaluate the effect of SAGE-718 on cognitive function in participants with Huntington's Disease (2022–2024)

Grant type:
Parexel International Pty Ltd
Researchers:
  • Trials Medical Specialist
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Parexel International Pty Ltd